Purchase Order 36C24826P0366
- Not listed
- This federal contract award was made by the Veterans Integrated Service Network 17 (VISN 17), which is part of the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA), to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 firm fixed-price purchase order is for the delivery of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The...
- This federal contract award, valued at $16,582.91, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 (VISN 8) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the procurement of Optune Plus Transducers, which are part of Novocure's Optune system that utilizes Tumor Treating Fields (TTFields) technology to treat glioblastoma, mesothelioma, and other solid tumor cancers in a non-invasive manner. The...
- The U.S. Department of Veterans Affairs' Veterans Integrated Service Network 12 awarded a firm fixed-price purchase order valued at $49,748.73 to Novocure Inc. for medical devices, with an ultimate completion date of May 30, 2025. The award was issued without a set-aside designation and represents a delivery order under Novocure's existing Federal Supply Schedule contract with the VA Veterans Health Administration. The performance location is Portsmouth, New Hampshire. Novocure Inc., a...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 10, awarded a $49,748.73 delivery order to Novocure Inc. on December 23, 2025, for Optune Plus transducers, with a completion date of March 23, 2026. This delivery order is issued under Novocure's Federal Supply Schedule contract for Medical Equipment and Supplies (FSS-65-II-A), a multiple-award vehicle valued at $28.85 million that runs through October 31, 2027. The award utilizes firm fixed-price pricing and...
- The Department of Veterans Affairs Veterans Integrated Service Network 21 awarded a $49,748.73 firm fixed-price delivery order to Novocure Inc. on December 17, 2025, for the provision of Optune prosthetic cancer treatment devices. This delivery order, with an ultimate completion date of March 31, 2026, is issued under Novocure's General Services Administration Medical Equipment and Supplies Federal Supply Schedule contract (FSS-65-II-A), a $28.85 million multiple-award vehicle established in...
- The Department of Veterans Affairs' Veterans Integrated Service Network 21 awarded a delivery order valued at approximately $49.7K to Novocure Inc. on December 19, 2025, for Optune transducers, with final completion scheduled for April 18, 2026. This firm fixed-price contract, placed under Novocure's existing Federal Supply Schedule contract for Medical Equipment and Supplies (FSS-65-II-A), requires performance in Fresno, California. No set-aside designation was utilized for this award. Novocure...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 10, awarded a delivery order to Novocure Inc. on January 20, 2026, valued at $49,748.73 for a 90-day initial provision of Optune Tumor Treating Fields (TTFields) devices. This delivery order, structured as a firm fixed-price contract with no set-aside designation, will be performed at the Portsmouth, New Hampshire VA medical facility and is scheduled for completion by April 7, 2026. Novocure Inc., a medical device...
- This is a federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, for the provision of its Optune Plus transducers and related support services. The contract, valued at $16,582.91, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) through its Veterans Integrated Service Network (VISN) 10. It is a delivery order under Novocure's $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which...
- This federal contract award was issued by the Veterans Integrated Service Network 2 (VISN 2), which is part of the Department of Veterans Affairs (VA) Veterans Health Administration (VHA), to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $33,165.82 firm-fixed-price purchase order is for the delivery of transducer products and is not associated with a set-aside designation. Novocure is the prime contractor and sole provider of the products and services under this...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 1 (VISN 1), awarded a $49,748.73 firm fixed-price delivery order to Novocure Inc. on October 29, 2025, for Optune Plus transducers with a completion date of January 28, 2026. This delivery order was issued under Novocure's existing Federal Supply Schedule (FSS) contract for Medical Equipment and Supplies (FSS-65-II-A), a $28.85 million multiple-award schedule contract effective through October 31, 2027. The award does...
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 8 (VISN 8) awarded a firm fixed-price purchase order to Novocure Inc. on January 16, 2026, with a ceiling value of $49,748.73 and an ultimate completion date of March 31, 2026. This contract, classified as a van conversion, will be performed in Fresno, California and carries no set-aside designation. Novocure Inc., a foreign-owned medical device manufacturer specializing in cancer treatment technologies, serves as the prime contractor with no subcontractor involvement. The award is issued under Novocure's existing Federal Supply Schedule contract (FSS-65-II-A) for Medical Equipment and Supplies, valued at $28.85 million through October 31, 2027, which was established to streamline VA procurement of the company's Optune Tumor Treating Fields therapy products and associated support services. This purchase order represents one of over 100 delivery orders and task orders the VA has issued to Novocure under the FSS vehicle, reflecting the company's role as the primary source provider for innovative, non-invasive cancer treatment technologies across the Veterans Health Administration network. Novocure's Optune system utilizes proprietary Tumor Treating Fields technology with FDA-approved applications for treating solid tumors including glioblastoma and mesothelioma. The contract supports the VA's strategic objective to expand veterans' access to cutting-edge oncology solutions at medical facilities nationwide, with similar delivery orders distributed across VISNs 1 through 23.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.7k | 1/19/26 |